期刊文献+

成纤维细胞因子21与腹型肥胖早期动脉粥样硬化相关性的研究 被引量:2

Relationship between fibroblast growth factor-21 and early atherosclerosis in patients with abdominal obesity
原文传递
导出
摘要 目的探讨腹型肥胖患者成纤维细胞因子21(FGF-21)与肱踝脉搏波传导速度(baPWV)、肱动脉内皮依赖性舒张功能(FMD)的关系。方法在体检人群中选择腹型肥胖(腹型肥胖组)患者80例及健康人(NGT组)80名,测定FGF-21、baPWV、肱动脉FMD及胰岛素抵抗指数(ln HOMA-IR)、HbA1C、血压及体脂含量(BFT)。结果腹型肥胖组baPWV、FGF-21、ln HOMA-IR高于NGT组(P<0.05或P<0.01),肱动脉FMD低于NGT组(P<0.05),FGF-21水平与BMI、BFT、WHR、TG、ln HOMA-IR、FIns呈正相关(r=0.456、0.355、0.231、0.257、0.218、0.220,P<0.05或P<0.01),Logistic回归分析发现,FGF-21、SBP、ln HOMA-IR是发生动脉粥样硬化(AS)的危险因素(OR=4.720、2.450、2.082,P<0.05)。结论腹型肥胖患者肱动脉FMD下降,而baPWV升高,FGF-21可能对预测其早期AS有意义。 Objective To investigate the relationship between fibroblast growth factor-21(FGF-21)and brachial-ankle pulse wave velocity(baPWV),brachial artery flow-mediated dilation(FMD)in patients with abdominal obesity. Methods All the participants were divided into two groups:abdominal obesity group(n=80)and NGT group(n=80).FGF-21,baPWV,brachial artery FMD,ln HOMA-IR,HbA1 c,blood pressure and body fat content(BFT)were measured in both groups. Results BaPWV,FGF-21 and ln HOMA-IR were significantly higher(P 0.05 or P 0.01),but brachial artery FMD was significantly lower(P〈0.05)in abdominal obesity group than in NGT group.FGF-21 level was positively correlated with BMI,BFT,WHR,TG,ln HOMA-IR and FIns(r=0.456,0.355,0.231,0.257,0.218,0.220,P〈0.05 or P〈0.01).Logistic regression analysis showed that FGF-21,SBP and ln(HOMA-IR)were associated with AS(OR=4.720,2.450,2.082,P〈0.05). Conclusion Brachial artery FMD decreases and baPWV increases in patients with abdominal obesity.FGF-21 may be helpful for early AS prediction.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2015年第10期888-890,共3页 Chinese Journal of Diabetes
关键词 腹型肥胖 成纤维细胞因子21 肱踝脉搏波传导速度 肱动脉内皮依赖性舒张功能 早期动脉粥样硬化 Abdominal obesity Fibroblast growth factor-21(FGF-21) Brachial-ankle pulse wave velocity(baPWV) Brachial artery flow-mediated dilation(FMD) Early atherosclerosis
  • 相关文献

参考文献2

二级参考文献25

  • 1Nishimura T, Nakatake Y, Konishi M,et al. Identification of a novel FGF, FGF21, preferentially expressed in the liver. Biochim Biophys Aeta,2000,1492:203-206.
  • 2Izumiya Y, Bina HA, Ouchi N, et al. FGF21 is an Akt- regulated myokine. FEBS Letters, 2008,582:3805-3810.
  • 3Coskun T, Bina HA, Schneider MA, et al. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology, 2008, 149: 6018-6027.
  • 4Xu J, Lloyd DJ, Hale C, et al. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice. Diabetes, 2009,58:250-259.
  • 5Kharitonenkov A, Wroblewski VJ, Koester A, et al. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology, 2007,148 : 774-781.
  • 6Lundasen T, Hunt MC, Nilsson LM, et al. PPAR alpha is a key regulator of hepatic FGF21. Biochem Biophys Res Commun, 2007,360:437-440.
  • 7Galman C, Lundason T, Kharitonenkov A, et al. The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPAR alpha activation in man. Cell metab,2008, 8 : 169-174.
  • 8Nishida M, Carley WW, Gerritsen ME, et al. Isolation and characterization of human and rat cardiac microvascular endothelial cells. Am J Physiol, 1993,264: 639-652.
  • 9Weisensee D, Seeger T, Bittner A, et al. Cocultures of fetal and adult cardiomyocytes yield rhythmically beating rod-shaped heart cells from adult rats. In Vitro, 1995,31: 190-195.
  • 10Nishimura T,Nakatake Y,Konishi M,Itoh N.Identification of a novel FGE FGF21,preferentially expressed in the liver.Biochim Biophys Acta 2000; 1492:203-206.

共引文献42

同被引文献19

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部